CSL Confirms Phase 3 Clinical Trial of New Therapy for Heart Attack Survivors
Global biotherapeutics leader CSL announced that it will proceed with a Phase 3 clinical trial for CSL112, the company’s novel therapy for reduction of...
New data supports the safety and efficacy of GSK’s Shingrix in preventing shingles in autologous haematopoietic stem cell transplant patients
GlaxoSmithKline plc announced that new data from a Phase III clinical study supports the safety and efficacy of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in...
Bayer, Loxo Oncology update clinical data from larotrectinib paediatric phase I SCOUT trial
Bayer and Loxo Oncology, Inc., a biopharmaceutical company based in Stamford, Connecticut, US, announced updated clinical data from the larotrectinib (LOXO-101) paediatric phase I...
Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes
Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide) injection 0.5 mg or...
Johnson & Johnson Announces Development Of Zika Vaccine
Johnson & Johnson announced that Janssen Vaccines & Prevention BV, part of the Janssen Pharmaceutical Companies, is working in partnership with the Beth Israel...
Scientists Create Successful Mass Production System for Bioengineered Livers
Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic transplant into people.
A team...
DNAtrix Announces First Pediatric Patient Treated with Oncolytic Virus DNX-2401
DNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced the intratumoral delivery of DNX-2401 to the first pediatric patient in...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...